Radiopharm Theranostics (RADX) names Bruce Michael Goodwin as director insider on Form 3

Rhea-AI Filing Summary

Radiopharm Theranostics Ltd filed an initial insider report for director Bruce Michael Goodwin. This Form 3 identifies him as a director but does not list any reportable transactions or derivative positions. The filing serves to register his status as an insider for future ownership reporting.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Goodwin Bruce Michael

(Last) (First) (Middle)

SUITE 1 LEVEL 3, 62 LYGON STREET

(Street)

CARLTON SOUTH, VICTORIA 3053

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Radiopharm Theranostics Ltd [ RADX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Bruce Michael Goodwin	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Radiopharm Theranostics (RADX) Form 3 for Bruce Michael Goodwin show?

The Form 3 identifies Bruce Michael Goodwin as a director of Radiopharm Theranostics Ltd. It reports no transactions, no derivative positions, and serves as his initial insider ownership registration with U.S. securities regulators for future reporting obligations.

Are there any share purchases or sales reported in RADX’s Form 3 for Bruce Michael Goodwin?

No. The Form 3 for Bruce Michael Goodwin reports zero buy and sell transactions. All transaction counts and share amounts are listed as 0, indicating the filing is purely an initial insider status report without trading activity.

Does the RADX Form 3 disclose any derivative securities for Bruce Michael Goodwin?

No derivative securities are disclosed. The derivative section is empty and the summary shows 0 derivative transactions. This means there are no options, warrants, or similar instruments reported for Goodwin in this initial insider filing.

What is the purpose of this Radiopharm Theranostics (RADX) Form 3 filing?

This Form 3 serves as an initial statement of beneficial ownership for director Bruce Michael Goodwin. It formally records his insider status so that any future trades or holdings in Radiopharm Theranostics securities can be reported on subsequent SEC forms.

Does the RADX Form 3 indicate whether Bruce Michael Goodwin is a 10% owner?

No, the filing indicates he is not a 10% owner. The metadata flags him as a director only, with the ten percent owner field set to 0, clarifying that his insider status is based on board membership rather than ownership size.